General News

DavosPharma to work with Wistar

Funding provided by Wellcome Trust

DavosPharma, which supplies pre-clinical development to commercialisation services to the pharmaceuticals industry, has signed a collaborative agreement with the Wistar Institute, a Philadelphia-based non-profit biomedical research body that focuses mainly on cancer. Under this, with funding by a Drug Discovery Award from the Wellcome Trust Institute, it will be able to supply DMPK and pre-clinical IND enabling studies and logistical support to advance the development of novel therapeutics for cancers associated with Epstein-Barr virus and other diseases.